Target intelligence / Profile preview

Bile salt metabolism

Molecular classification
Enzyme, Transporter, Receptor, Transcription factor, Other
01

Overview

Bile salt metabolism refers to the complex biochemical pathway responsible for the synthesis, secretion, transport, and recycling of bile acids, which are essential for dietary lipid absorption and systemic metabolic signaling (Chiang, J. Y. L., 2013, Comprehensive Physiology). This process begins in the liver with the conversion of cholesterol into primary bile acids, primarily regulated by the rate-limiting enzyme cholesterol 7-alpha-hydroxylase (CYP7A1) (StatPearls, 2023, Physiology, Bile Acids). Bile acids are then conjugated, stored in the gallbladder, and secreted into the duodenum to facilitate fat emulsification and the absorption of fat-soluble vitamins (Dawson, P. A., 2015, Journal of Lipid Research). The majority of bile acids are efficiently reclaimed from the terminal ileum by the apical sodium-dependent bile acid transporter (ASBT) and returned to the liver via the portal circulation, a process known as enterohepatic circulation (UniProt, 2024, SLC10A2). Dysregulation of this pathway is central to the pathogenesis of cholestatic liver diseases, gallstones, and metabolic disorders like nonalcoholic steatohepatitis (NASH) (Trauner, M., 2022, Gut). Therapeutic strategies targeting this pathway include farnesoid X receptor (FXR) agonists like obeticholic acid to reduce synthesis and ASBT inhibitors like odevixibat to increase fecal excretion (FDA, 2021, Bylvay Label).

Other names
Bile acid metabolismEnterohepatic circulation of bile acidsBile acid signaling pathwayBile acid synthesis and transport
02

Mechanism of action

Drugs modulate this pathway by acting as agonists for nuclear receptors like FXR to suppress bile acid synthesis, inhibiting intestinal transporters like ASBT to prevent reabsorption, or chemically sequestering bile acids in the gut to promote fecal excretion (Trauner, M., & Fuchs, C. D., 2022, Gut).

03

Biological functions

Lipid digestionCholesterol homeostasisMetabolic signalingGlucose regulationFat-soluble vitamin absorption
04

Disease associations

CholestasisPrimary Biliary CholangitisPrimary Sclerosing CholangitisNonalcoholic SteatohepatitisDyslipidemiaGallstones
05

Safety considerations

PruritusGastrointestinal distress (diarrhea)LDL cholesterol elevationFat-soluble vitamin malabsorptionPotential hepatotoxicity
06

Interacting drugs

Obeticholic acid

6 more in the full profile.

07

Biomarkers

Serum total bile acids7α-hydroxy-4-cholesten-3-one (C4)Fibroblast Growth Factor 19 (FGF19)Alkaline phosphatase (ALP)Bilirubin

Beyond the preview

Go deeper on Bile salt metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bile salt metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call